Literature DB >> 28007595

The Notch ligand delta-like 3 promotes tumor growth and inhibits Notch signaling in lung cancer cells in mice.

San-Ming Deng1, Xian-Chun Yan2, Liang Liang2, Li Wang2, Yuan Liu2, Juan-Li Duan3, Zi-Yan Yang2, Tian-Fang Chang4, Bai Ruan3, Qi-Jun Zheng5, Hua Han6.   

Abstract

Although it has been suggested that Dll3, one of the Notch ligands, promotes the proliferation and inhibits the apoptosis of cancer cells, the role of Dll3 in cancers remains unclear. In this study, we found that in the murine Lewis lung carcinoma (LLC) cells, the level of Dll3 mRNA changed upon tumor microenvironment (TME) stimulation, namely, decreased under hypoxia or stimulated with tumor necrosis factor (TNF)-α. Dll3 was also expressed at higher level in human lung carcinoma tissues than in the para-carcinoma tissues. Overexpression of Dll3 in LLC cells promoted cell proliferation and reduced apoptosis in vitro, and enhanced tumor growth when inoculated in vivo in mice. The Dll3-mediated proliferation could be due to increased Akt phosphorylation in LLC cells, because an Akt inhibitor counteracted Dll3-induced proliferation. Moreover, Dll3 overexpression promoted PI3K/Akt signaling through inhibiting Notch signaling.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Delta-like 3; Hypoxia; Lung cancer; Notch; TNF-α

Mesh:

Substances:

Year:  2016        PMID: 28007595     DOI: 10.1016/j.bbrc.2016.12.117

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).

Authors:  Megumi Furuta; Jun Sakakibara-Konishi; Hajime Kikuchi; Hiroshi Yokouchi; Hiroshi Nishihara; Hiroyuki Minemura; Masao Harada; Shigeo Yamazaki; Kenji Akie; Yuka Fujita; Kei Takamura; Tetsuya Kojima; Toshiyuki Harada; Yoshinori Minami; Naomi Watanabe; Satoshi Oizumi; Hiroyuki Suzuki; Masaharu Nishimura; Hirotoshi Dosaka-Akita; Hiroshi Isobe
Journal:  Oncologist       Date:  2019-05-08

2.  TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment Selection.

Authors:  Aya Miyagawa-Hayashino; Satoru Okada; Naoko Takeda-Miyata; Yasutoshi Takashima; Tadaaki Yamada; Yoshizumi Takemura; Junji Uchino; Masayoshi Inoue; Koichi Takayama; Eiichi Konishi
Journal:  Appl Immunohistochem Mol Morphol       Date:  2021-04-01

3.  Delta-like 3 localizes to neuroendocrine cells and plays a pivotal role in gastrointestinal neuroendocrine malignancy.

Authors:  Kentaro Matsuo; Kohei Taniguchi; Hiroki Hamamoto; Yuko Ito; Sugiko Futaki; Yosuke Inomata; Takafumi Shima; Mitsuhiro Asakuma; Sang-Woong Lee; Keitaro Tanaka; Junji Okuda; Yoichi Kondo; Kazuhisa Uchiyama
Journal:  Cancer Sci       Date:  2019-08-14       Impact factor: 6.716

4.  JAG2/Notch2 inhibits intervertebral disc degeneration by modulating cell proliferation, apoptosis, and extracellular matrix.

Authors:  Jun Long; Xiaobo Wang; Xianfa Du; Hehai Pan; Jianru Wang; Zemin Li; Hui Liu; Xudong Li; Zhaomin Zheng
Journal:  Arthritis Res Ther       Date:  2019-10-16       Impact factor: 5.156

Review 5.  The Role of DLLs in Cancer: A Novel Therapeutic Target.

Authors:  Meng-Xi Xiu; Yuan-Meng Liu; Bo-Hai Kuang
Journal:  Onco Targets Ther       Date:  2020-05-07       Impact factor: 4.147

6.  Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer.

Authors:  Yoshitaka Isobe; Kazuhide Sato; Yuko Nishinaga; Kazuomi Takahashi; Shunichi Taki; Hirotoshi Yasui; Misae Shimizu; Rena Endo; Chiaki Koike; Noriko Kuramoto; Hiroshi Yukawa; Shota Nakamura; Takayuki Fukui; Koji Kawaguchi; Toyofumi F Chen-Yoshikawa; Yoshinobu Baba; Yoshinori Hasegawa
Journal:  EBioMedicine       Date:  2020-01-23       Impact factor: 8.143

Review 7.  Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities.

Authors:  Miriam Grazia Ferrara; Alessio Stefani; Michele Simbolo; Sara Pilotto; Maurizio Martini; Filippo Lococo; Emanuele Vita; Marco Chiappetta; Alessandra Cancellieri; Ettore D'Argento; Rocco Trisolini; Guido Rindi; Aldo Scarpa; Stefano Margaritora; Michele Milella; Giampaolo Tortora; Emilio Bria
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

Review 8.  Management of Large Cell Neuroendocrine Carcinoma.

Authors:  Virginia Corbett; Susanne Arnold; Lowell Anthony; Aman Chauhan
Journal:  Front Oncol       Date:  2021-08-27       Impact factor: 6.244

9.  Potential prognostic value of delta-like protein 3 in small cell lung cancer: a meta-analysis.

Authors:  Benchao Chen; Heng Li; Chao Liu; Shuting Wang; Feiyue Zhang; Li Zhang; Mingjie Li; Gaofeng Li
Journal:  World J Surg Oncol       Date:  2020-08-26       Impact factor: 2.754

10.  DLL3 (delta-like protein 3) expression correlates with stromal desmoplasia and lymph node metastases in medullary thyroid carcinomas.

Authors:  M Ingenwerth; T Brandenburg; D Führer-Sakel; M Goetz; F Weber; H Dralle; H-U Schildhaus; K W Schmid; S Theurer
Journal:  Endocr Connect       Date:  2021-03       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.